Welcome to LookChem.com Sign In|Join Free
  • or
1‐benzyl 4‐tert‐butyl (2S)‐2‐(2‐methoxy‐2‐oxoethyl)piperazine‐1,4‐dicarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

314741-49-6

Post Buying Request

314741-49-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

314741-49-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 314741-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,4,7,4 and 1 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 314741-49:
(8*3)+(7*1)+(6*4)+(5*7)+(4*4)+(3*1)+(2*4)+(1*9)=126
126 % 10 = 6
So 314741-49-6 is a valid CAS Registry Number.

314741-49-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name [2S]-1-benzyloxycarbonyl-4-t-butoxycarbonyl-2-methoxycarbonylmethylpiperazine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:314741-49-6 SDS

314741-49-6Relevant academic research and scientific papers

QUINOLINE DERIVATIVES AS ANTIBACTERIALS

-

Page 15, (2010/02/06)

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or N-oxide thereof: corresponding novel medicaments, pharmaceutical compositions and/or methods of

Compounds and methods for the treatment of neoplastic disease

-

, (2008/06/13)

A method of modulating the activity of a aberrant cell topoisomerase enzyme involving contacting the enzyme with a compound that inhibits enzyme-mediated cleavage of a polynucleotide substrate with which the enzyme is in complex. Pharmaceutical compositions containing such compounds may be used to treat neoplasias or to inhibit the growth of certain cancer cells. Screening methods can be employed to identify other compounds for these uses.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 314741-49-6